Status: Recruiting
CorWave LVAS FIH Study
The study is a prospective, multi-center, non-randomized trial to evaluate the safety and effectiveness of the CorWave LVAS for the treatment of advanced heart failure patients.
Participants needed: 20
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: CorWaveUpdated: Feb 9, 2026Locations: 2
Eligibility criteria
Subject or legal representative has signed Informed Consent Form [+8]
Heart failure (HF) due to or associated with uncorrected thyroid disease, obstru... [+29]